↓ Skip to main content

Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

Overview of attention for article published in BMC Cancer, September 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
2 X users
patent
2 patents

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study
Published in
BMC Cancer, September 2009
DOI 10.1186/1471-2407-9-333
Pubmed ID
Authors

Ivette F Emery, Chiara Battelli, Paul L Auclair, Kathleen Carrier, Daniel M Hayes

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 5%
Unknown 21 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 36%
Other 3 14%
Student > Bachelor 3 14%
Student > Doctoral Student 2 9%
Student > Master 2 9%
Other 2 9%
Unknown 2 9%
Readers by discipline Count As %
Medicine and Dentistry 12 55%
Agricultural and Biological Sciences 4 18%
Biochemistry, Genetics and Molecular Biology 2 9%
Business, Management and Accounting 1 5%
Chemistry 1 5%
Other 0 0%
Unknown 2 9%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 December 2015.
All research outputs
#4,176,968
of 22,818,766 outputs
Outputs from BMC Cancer
#1,000
of 8,300 outputs
Outputs of similar age
#16,116
of 93,520 outputs
Outputs of similar age from BMC Cancer
#7
of 34 outputs
Altmetric has tracked 22,818,766 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,300 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,520 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 34 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.